Trials / Completed
CompletedNCT01198717
Pediatric Disease Registry in Essential Thrombocythaemia (ET)
Multicentre Paediatric Disease Registry in Essential Thrombocythaemia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Shire · Industry
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the progression of ET in children (aged 6-17years inclusive) over a period of 5 years maximum. The study will also assess how children are diagnosed, treatment options for those children with symptoms and events related to their ET and the outcomes of those treatments.
Conditions
Timeline
- Start date
- 2010-09-28
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2010-09-10
- Last updated
- 2021-03-17
Locations
32 sites across 8 countries: Czechia, France, Germany, Greece, Italy, Spain, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT01198717. Inclusion in this directory is not an endorsement.